ADJUVANT TREATMENT IN OPERABLE STAGE-II AND STAGE-III RECTAL-CANCER

Citation
A. Picciocchi et al., ADJUVANT TREATMENT IN OPERABLE STAGE-II AND STAGE-III RECTAL-CANCER, Tumori, 81(3), 1995, pp. 109-113
Citations number
26
Categorie Soggetti
Oncology
Journal title
TumoriACNP
ISSN journal
03008916
Volume
81
Issue
3
Year of publication
1995
Supplement
S
Pages
109 - 113
Database
ISI
SICI code
0300-8916(1995)81:3<109:ATIOSA>2.0.ZU;2-C
Abstract
Aims and Background: To date adjuvant treatments of rectal cancer gene rally include radiotherapy and more recently a combination of radiothe rapy and chemotherapy. Trials have benn generally restricted to patien ts with stage II and III rectal cancer. The purpose of the present stu dy is to determine the efficacy of a preoperative combination of radia tion therapy and chemotherapy in operable locally advanced rectal canc er. Methods: From March 1990 to June 1994, 58 patients with histologic ally documented adenocarcinoma of the rectum entered our protocol. 35 neoplasms were located in the lower third of the rectum and the remain ing 23 in the middle third. At pre-treatment clinical staging 46 tumor s were judged as stage III and 12 as stage II. Chemotherapy and radiot herapy were started jointly on day one of the treatment. Mitomycin-C w as given as a bolus intravenous at a dosage of 10 mg/m2, the first day . 8-Fluorouracil was given in a dosage of 1000 mg./m(2)/day as a conti nuous 24 h infusion for 4 days. Radiation therapy was given at a total dosage of 37.8 Gy. Surgery was generally performed four to five weeks following completion of the radiation therapy. Results: Patients comp liance to the treatment was 96 percent. A reduction of tumor size > 50 percent was observed in 65 percent of patients. Tumor distance from a nal canal increased in 75 percent of patients. Morbidity rate was 31 p ercent; no postoperative mortality was reported. Histological examinat ion of surgical specimens showed that in 54 percent of patients tumor disappeared or was confined to the rectum; there was no evidence of tu mor cells in 5 cases and stage I lesions were diagnosed in 19 cases (3 5 percent). Preliminary data on recurrences show a 5 percent local rec urrence rate and a 7 percent distant metastases rate. Conclusions: It may be concluded that preoperative radiochemotherapy is generally well tolerated; surgery does not present additional technical difficulties ; the effect of stage reduction has been observed in a consistent numb er of cases.